Investing in growth stocks can lead to significant returns for investors in the long run. But oftentimes, the best returns come from smaller stocks, which have modest market values. These stocks can be risky options, but due to their low valuations, they tend to have the most room to rise higher if their ...
motleyfoolusx:rxrx
Everyone wants a piece of the fast-growing and highly promising artificial intelligence (AI) market. Various famous names on Wall Street have somewhat different picks in the field, although the same few select corporations seem to get most of the attention. Perhaps the average investor can learn a lot ...
motleyfoolusx:rxrxusx:meta
Making a million dollars on a stock investment is one of those classic goals you hear many investors say they dream about. And in some rare cases, the dream of a massive return that generates life-changing profits does come true. Investors who took a chance on high-flying Nvidia (NASDAQ: NVDA) back in ...
motleyfoolusx:nvdausx:rxrx
Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown, equities will fall, and many won't deliver anything approaching decent returns for years after. So it's important ...
motleyfoolusx:vktxusx:rxrx
As you may have heard, there's a new trend in biotech lingo wherein companies call themselves "TechBio" rather than "biotech" to emphasize their forward-thinking about the role of information technology. Biotechs like Ginkgo Bioworks (NYSE: DNA), Recursion Pharmaceuticals (NASDAQ: RXRX), and Schrödinger ...
motleyfoolusx:sdgrusx:rxrxusx:dna
What have Nvidia and the FTSE 100 got in common? Well, not much in all fairness. But the leader in artificial intelligence (AI) computing and the Footsie’s Scottish Mortgage Investment Trust do both have investments in Recursion Pharmaceuticals (NASDAQ: RXRX). Between them, they own around a 10% stake ...
motleyfoolukusx:rxrx
